Pregabalin for Abdominal Pain From Adhesions
Stopped early · Phase 4 · Has a placebo group
Conditions studied: Abdominal Pain, Surgical Adhesions
In brief
The purpose of this study is to evaluate if pregabalin demonstrates significant reduction in abdominal pain from adhesions.
Key facts
- Study ID
- NCT00310765
- Run by
- Henry Ford Health System
- People needed
- 18
- Starts
- 2006-03-01
- Expected to finish
- 2008-08-01
- Last updated by the study team
- 2023-10-23
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- Must have history of prior surgery and documented adhesions during laparoscopy or open laparotomy within 5 years
- Must have undergone an evaluation to exclude other causes of abdominal pain
- Abdominal pain must be present for greater than three months duration
You may not qualify if…
- Patients that are pregnant or breast feeding
- Prior treatment with gabapentin, pregabalin or demonstrated sensitivity to these drugs
- Patients who are immunocompromised
- Patients with significant hepatic or renal insufficiency, or any significant hematologic disorder
- History of illicit alcohol or drug abuse within one year
- Documented serious or unstable medical or psychological condition
- Malignancy within the past 5 years other than in situ squamous cell carcinoma of the skin
Where it is running
- Henry Ford Health System — West Bloomfield, Michigan, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.